Glaukos (GKOS) Earnings Date, Estimates & Call Transcripts → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free GKOS Stock Alerts $108.24 +1.33 (+1.24%) (As of 01:54 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 7EstimatedActual EPS (May. 1) -$0.70 Missed By -$0.12 Consensus EPS (May. 1) -$0.58 Read Call TranscriptListen to Call Get Glaukos Earnings AlertsEnter your email address below to receive the latest news and earnings results for GKOS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueGKOS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GKOS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlace1970’s computer coder Issues Shocking AI WarningLouis Navellier has spent four decades building a billion-dollar empire on the back of big data and technology… Now he's stepping forward with a shocking warning about how AI will soon impact the wealth of everyday Americans.Click here to watch his new video ASAP Glaukos Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242($0.66)($0.62)($0.64) Q2 20242($0.56)($0.53)($0.55) Q3 20242($0.56)($0.52)($0.54) Q4 20242($0.62)($0.39)($0.51) FY 20248($2.40)($2.06)($2.23) Q1 20252($0.47)($0.43)($0.45) Q2 20252($0.48)($0.36)($0.42) Q3 20252($0.43)($0.40)($0.42) Q4 20252($0.41)($0.35)($0.38) FY 20258($1.79)($1.54) ($1.67)GKOS Earnings Date and InformationGlaukos last released its earnings results on May 1st, 2024. The medical instruments supplier reported ($0.70) EPS for the quarter, missing the consensus estimate of ($0.58) by $0.12. The firm had revenue of $85.60 million for the quarter, compared to analysts' expectations of $79.60 million. Its revenue for the quarter was up 15.8% on a year-over-year basis. Glaukos has generated ($2.88) earnings per share over the last year (($2.88) diluted earnings per share). Earnings for Glaukos are expected to grow in the coming year, from ($2.20) to ($1.36) per share. Glaukos has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based off prior year's report dates.Read More Glaukos Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/7/2024Estimated)------- 5/1/2024Q1 2024($0.58)($0.70)($0.12)($0.58)$79.60 million$85.60 million 2/21/2024Q4 2023($0.56)($0.63)($0.07)($0.51)$81.00 million$82.40 million 11/1/2023Q3 2023($0.56)($0.50)+$0.06($0.37)$75.25 million$78.05 million 8/2/2023Q2 2023($0.57)($0.55)+$0.02($0.42)$74.73 million$80.40 million 5/3/2023Q1 2023($0.61)($0.59)+$0.02($0.46)$67.74 million$73.90 million 2/22/2023Q4 2022($0.56)($0.53)+$0.03($0.40)$67.71 million$71.23 million Get the Latest News and Ratings for GKOS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Glaukos and its competitors with MarketBeat's FREE daily newsletter. 11/2/2022Q3 2022($0.53)($0.45)+$0.08($0.32)$67.88 million$71.27 million 8/3/2022Q2 2022($0.44)($0.83)($0.39)($0.70)$67.61 million$72.69 million5/4/2022Q1 2022($0.52)($0.38)+$0.14($0.87)$60.85 million$67.70 million 2/22/2022Q4 2021($0.37)($0.31)+$0.06($0.15)$67.27 million$73.24 million 11/4/2021Q3 2021($0.24)$0.13+$0.37($0.51)$72.73 million$74.71 million 8/5/2021Q2 2021($0.24)($0.11)+$0.13$0.16$71.00 million$78.09 million Glaukos Earnings - Frequently Asked Questions When is Glaukos's earnings date? Glaukos has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based off last year's report dates. Learn more on GKOS's earnings history. Did Glaukos beat their earnings estimates last quarter? In the previous quarter, Glaukos (NYSE:GKOS) missed the analysts' consensus estimate of ($0.58) by $0.12 with a reported earnings per share (EPS) of ($0.70). Learn more on analysts' earnings estimate vs. GKOS's actual earnings. How can I listen to Glaukos's earnings conference call? The conference call for Glaukos's latest earnings report can be listened to online. Listen to Conference Call How can I read Glaukos's conference call transcript? The conference call transcript for Glaukos's latest earnings report can be read online. Read Transcript How much revenue does Glaukos generate each year? Glaukos (NYSE:GKOS) has a recorded annual revenue of $326.43 million. How much profit does Glaukos generate each year? Glaukos (NYSE:GKOS) has a recorded net income of -$134.66 million. GKOS has generated -$2.88 earnings per share over the last four quarters. What is Glaukos's EPS forecast for next year? Glaukos's earnings are expected to grow from ($2.20) per share to ($1.36) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Haemonetics Earnings Date Merit Medical Systems Earnings Date iRhythm Technologies Earnings Date Axonics Earnings Date Globus Medical Earnings Date PROCEPT BioRobotics Earnings Date ICU Medical Earnings Date Tandem Diabetes Care Earnings Date Inspire Medical Systems Earnings Date Integra LifeSciences Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NYSE:GKOS) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange348 million Americans lives to END as we know it?The Oxford ClubThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Glaukos Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
